Anna E. Coghill

3.2k total citations
83 papers, 1.8k citations indexed

About

Anna E. Coghill is a scholar working on Oncology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Anna E. Coghill has authored 83 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 24 papers in Pathology and Forensic Medicine and 23 papers in Epidemiology. Recurrent topics in Anna E. Coghill's work include Viral-associated cancers and disorders (49 papers), Polyomavirus and related diseases (25 papers) and Lymphoma Diagnosis and Treatment (19 papers). Anna E. Coghill is often cited by papers focused on Viral-associated cancers and disorders (49 papers), Polyomavirus and related diseases (25 papers) and Lymphoma Diagnosis and Treatment (19 papers). Anna E. Coghill collaborates with scholars based in United States, Taiwan and Australia. Anna E. Coghill's co-authors include Meredith S. Shiels, Eric A. Engels, Gita Suneja, Allan Hildesheim, Ruth M. Pfeiffer, Polly A. Newcomb, John D. Potter, Susan S. Devesa, Teresa M. Darragh and Aimée R. Kreimer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bioinformatics.

In The Last Decade

Anna E. Coghill

77 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna E. Coghill United States 23 1.2k 558 477 369 214 83 1.8k
Maureen Reiner United States 22 707 0.6× 153 0.3× 295 0.6× 218 0.6× 113 0.5× 51 1.4k
Shehnaz K. Hussain United States 21 549 0.4× 327 0.6× 269 0.6× 121 0.3× 88 0.4× 53 1.3k
François Lefrère France 26 822 0.7× 362 0.6× 1.1k 2.4× 157 0.4× 247 1.2× 79 2.9k
Timothy P. Cooley United States 27 780 0.6× 482 0.9× 408 0.9× 172 0.5× 879 4.1× 52 2.0k
Sophie Prévôt France 26 457 0.4× 852 1.5× 341 0.7× 322 0.9× 224 1.0× 66 3.1k
Lior H. Katz Israel 23 497 0.4× 768 1.4× 192 0.4× 524 1.4× 58 0.3× 92 2.1k
Leonardo Potenza Italy 22 483 0.4× 295 0.5× 307 0.6× 126 0.3× 172 0.8× 88 1.4k
Ibrahim Aldoss United States 29 899 0.7× 250 0.4× 244 0.5× 115 0.3× 122 0.6× 190 2.5k
M Kalaycio United States 24 626 0.5× 224 0.4× 277 0.6× 81 0.2× 146 0.7× 76 1.8k
Lucine Vuitton France 21 300 0.2× 735 1.3× 840 1.8× 1.2k 3.4× 289 1.4× 83 2.5k

Countries citing papers authored by Anna E. Coghill

Since Specialization
Citations

This map shows the geographic impact of Anna E. Coghill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna E. Coghill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna E. Coghill more than expected).

Fields of papers citing papers by Anna E. Coghill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna E. Coghill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna E. Coghill. The network helps show where Anna E. Coghill may publish in the future.

Co-authorship network of co-authors of Anna E. Coghill

This figure shows the co-authorship network connecting the top 25 collaborators of Anna E. Coghill. A scholar is included among the top collaborators of Anna E. Coghill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna E. Coghill. Anna E. Coghill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Sarah S., Julia M. Francis, Ruth M. Pfeiffer, et al.. (2025). Sex Differences in Anti–Epstein-Barr Virus Antibody Responses. The Journal of Infectious Diseases. 232(4). e671–e675. 2 indexed citations
2.
Islam, Jessica Y., Yi Guo, Kea Turner, et al.. (2024). Inequities in palliative care delivery to patients with HIV and stage IV cancers in the United States (2004-2020). JNCI Cancer Spectrum. 9(2).
3.
Gillis, Nancy, Christelle Colin, Ryan M. Putney, et al.. (2024). Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and Cancer. The Journal of Infectious Diseases. 230(3). 680–688. 3 indexed citations
4.
Islam, Jessica Y., et al.. (2023). Cancer treatment delays among cancer patients living with HIV during the COVID‐19 pandemic in the United States. Cancer Medicine. 12(18). 18717–18728. 2 indexed citations
5.
Islam, Jessica Y., Letícia Nogueira, Gita Suneja, Anna E. Coghill, & Tomi Akinyemiju. (2022). Palliative Care Use Among People Living With HIV and Cancer: An Analysis of the National Cancer Database (2004-2018). JCO Oncology Practice. 18(10). e1683–e1693. 12 indexed citations
6.
Coghill, Anna E., Naomi C. Brownstein, Sweta Sinha, et al.. (2022). Patient-Reported Outcomes in Cancer Patients with HIV. Cancers. 14(23). 5889–5889. 3 indexed citations
7.
Liu, Zhiwei, Kelly J. Yu, Anna E. Coghill, et al.. (2022). Utility of Epstein–Barr Virus DNA in Nasopharynx Swabs as a Reflex Test to Triage Seropositive Individuals in Nasopharyngeal Carcinoma Screening Programs. Clinical Chemistry. 68(7). 953–962. 16 indexed citations
8.
Chiao, Elizabeth Y., Anna E. Coghill, Valeria Fink, et al.. (2021). The effect of non-AIDS-defining cancers on people living with HIV. The Lancet Oncology. 22(6). e240–e253. 43 indexed citations
9.
Simon, Julia, Zhiwei Liu, Nicole Brenner, et al.. (2020). Validation of an Epstein-Barr Virus Antibody Risk Stratification Signature for Nasopharyngeal Carcinoma by Use of Multiplex Serology. Journal of Clinical Microbiology. 58(5). 13 indexed citations
10.
Lee, Mei–Hsuan, Yu‐Han Huang, Anna E. Coghill, et al.. (2020). Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan. The Journal of Infectious Diseases. 223(3). 441–444. 5 indexed citations
11.
Liu, Zhiwei, Ruth F. Jarrett, Henrik Hjalgrim, et al.. (2019). Evaluation of the antibody response to the EBV proteome in EBV‐associated classical Hodgkin lymphoma. International Journal of Cancer. 147(3). 608–618. 12 indexed citations
12.
Coghill, Anna E., Carla Proietti, Zhiwei Liu, et al.. (2019). The Association between the Comprehensive Epstein–Barr Virus Serologic Profile and Endemic Burkitt Lymphoma. Cancer Epidemiology Biomarkers & Prevention. 29(1). 57–62. 17 indexed citations
13.
Liu, Zhiwei, Kelly J. Yu, Anna E. Coghill, et al.. (2019). Multilaboratory Assessment of Epstein-Barr Virus Serologic Assays: the Case for Standardization. Journal of Clinical Microbiology. 57(11). 7 indexed citations
14.
Yu, Guoqin, Anna E. Coghill, Kelly J. Yu, et al.. (2019). Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma. Scientific Reports. 9(1). 29 indexed citations
15.
Coghill, Anna E., Ruth M. Pfeiffer, Carla Proietti, et al.. (2018). Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan. Clinical Cancer Research. 24(6). 1305–1314. 47 indexed citations
16.
Coghill, Anna E., Ruth M. Pfeiffer, Meredith S. Shiels, & Eric A. Engels. (2017). Excess Mortality among HIV-Infected Individuals with Cancer in the United States. Cancer Epidemiology Biomarkers & Prevention. 26(7). 1027–1033. 74 indexed citations
17.
Coghill, Anna E., Wei Bu, Hanh Nguyen, et al.. (2016). High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma. Clinical Cancer Research. 22(14). 3451–3457. 32 indexed citations
18.
Shiels, Meredith S., Aimée R. Kreimer, Anna E. Coghill, Teresa M. Darragh, & Susan S. Devesa. (2015). Anal Cancer Incidence in the United States, 1977–2011: Distinct Patterns by Histology and Behavior. Cancer Epidemiology Biomarkers & Prevention. 24(10). 1548–1556. 116 indexed citations
19.
Coghill, Anna E., Wan‐Lun Hsu, Ruth M. Pfeiffer, et al.. (2014). Epstein–Barr Virus Serology as a Potential Screening Marker for Nasopharyngeal Carcinoma among High-Risk Individuals from Multiplex Families in Taiwan. Cancer Epidemiology Biomarkers & Prevention. 23(7). 1213–1219. 52 indexed citations
20.
Phipps, Amanda I., Daniel D. Buchanan, Karen W. Makar, et al.. (2012). BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics. Cancer Epidemiology Biomarkers & Prevention. 21(10). 1792–1798. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026